Asaf Zviran co-founded Israel’s C2i Genomics (see here previously). It has developed a blood test that can identify whether a cancer patient will survive after the tumor has been completely removed, or whether further chemotherapy is necessary.

https://www.israel21c.org/a-blood-test-that-can-identify-recurrent-cancer/